Evaluation of Health Related Quality of Life in Cancer Patients Receiving Chemotherapy

Abdelrahim Saad Shoulah; Mahmoud Ali Saleh; Shereen Mohamed Abdelwahab; Mona Ahmad Elawady; Eman Fadel Elsheikh

doi:doi:10.11648/j.sjph.s.2017050501.11

| Peer-Reviewed

Evaluation of Health Related Quality of Life in Cancer Patients Receiving Chemotherapy

Abdelrahim Saad Shoulah, Mahmoud Ali Saleh, Shereen Mohamed Abdelwahab, Mona Ahmad Elawady, Eman Fadel Elsheikh

Published in Science Journal of Public Health (Volume 5, Issue 5-1)

Received: 11 January 2017 Accepted: 18 January 2017 Published: 14 February 2017

Views: Downloads:

Download PDF

Share This Article

Twitter
Linked In
Facebook

Abstract

Background: Cancer is considered as the second leading cause of death worldwide. Objectives: To evaluate health-related quality of life (HRQOL) among cancer patients receiving chemotherapy and to identify the most important determinants that affect them. Methods: This cross-sectional study included 190 cancer patients who have been received chemotherapy at the day care clinics in Nasser Institute Cancer Center (NICC). To address our subject, we analyzed HRQOL, as measured by the Functional Assessment of Cancer Therapy-General questionnaire (FACT-G), Arabic Version 4, and depicted the complex relations among physical, psychological, social, and cultural factors. Results: From cancer patients (190) [aged from 23 to 81 years (50.63±11.79)] 153 patients (80.53%) were females. FACT-G total score ranged from 21.2 to 87 (63.24±12.74) which is considered relatively poor (the physical and functional domains were more affected). HRQOL of the study group was not affected by gender, employment status, education level, smoking habits or marital status while it was negatively correlated with age, time since diagnosis of cancer, and disease stage. Patients’ HRQOL shown to be affected by the presence of many variables like low-performance status as evaluated by Eastern Cooperative Oncology Group (ECOG) scale, associated comorbidities, exposure to radiotherapy, history of surgery, and absence of menstrual status in female patients. A positive correlation was found between HRQOL and higher body mass index (BMI), and it was observed that the HRQOL of patients with higher perceived financial status was better. Conclusion: The HRQOL of cancer patients tended to be lower than the norms of the healthy people. Preplanned health programs should be designed to support early disease diagnosis, optimizing treatment choices, controlling of associated comorbidities, improving patients’ performance status as well as working on improving health insurance coverage.

Published in	Science Journal of Public Health (Volume 5, Issue 5-1) This article belongs to the Special Issue Malnutrition in Developing Countries
DOI	10.11648/j.sjph.s.2017050501.11
Page(s)	1-7
Creative Commons	This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.
Copyright	Copyright © The Author(s), 2017. Published by Science Publishing Group

Keywords

Cancer, Chemotherapy, Health Related Quality of Life

References

[1]	Siegel R, Naishadham D, Jemal A. Cancer statistics 2012. CA Cancer J Clin. 2012 Jan-Feb; 62 (1): 10-29.
[2]	American Cancer Society. Global Cancer Facts & Figures 2nd Edition. Atlanta: American Cancer Society; 2011. Available at: http://oralcancerfoundation.org/wp-content/uploads/2016/03/acspc-027766.pdf, accessed on 6th Jan 2017.
[3]	Lianqi Liu, Lavinia Fiorentino, Michelle Rissling, Loki Natarajan, Barbara A. Parker, Joel E. Dimsdale, Paul J. Mills, Georgia Robins Sadler, Sonia Ancoli-Israel. Decreased Health-Related Quality of Life in Women with Breast Cancer is Associated with Poor Sleep. Behav Sleep Med. 2013 July; 11 (3): 189–206.
[4]	Priestman T. Cancer Chemotherapy in Clinical Practice. Second edition. Springer. 2012. DOI 10.1007/978-0-85729-727-3.
[5]	Pockaj BA, Degnim AC, Boughey JC, Gray RJ, McLaughlin SA, Dueck AC, Perez EA, Halyard MY, Frost MH, Cheville AL, Sloan JA. Quality of life after breast cancer surgery: What have we learned and where should we go next. J Surg Oncol. 2009 Jun 1; 99 (7): 447-455.
[6]	Klee MC, King MT, Machin D, Hansen HH. A clinical model for quality of life assessment in cancer patients receiving chemotherapy. Ann Oncol. 2000; 11 (1): 23-30.
[7]	Siddiqui F, Kachnic LA, Movsas B. Quality-of-life outcomes in oncology. Hematol Oncol Clin North Am. 2006 Feb; 20 (1): 165–185.
[8]	Cella D, Tulsky D, Gray G, Linn E, Bonomi A, Silberman M, Yellen SB, Winicour P, Brannon J. The Functional Assessment of Cancer Therapy Scale: development and validation of the general measure. J Clin Oncol 1993; 11 (3): 570-579.
[9]	Cella D, Hernandez L, Bonomi AE, Corona M, Vaquero M, Shiomoto G, Baez L. Spanish language translation and initial validation of the functional assessment of cancer therapy quality of life instrument. Med Care 1998 Sep; 36 (9): 1407-1418
[10]	Dapueto JJ, Servente L, Francolino C, Hahn EA. Determinants of quality of life in patients with cancer. Cancer. 2005 Mar 1; 103 (5): 1072-1081.
[11]	Ganz PA, Greendale GA, Petersen L, Kahn B, Bower JE. Breast cancer in younger women: reproductive and late health effects of treatment. J Clin Oncol. 2003 Nov 15; 21 (22): 4184-4193.
[12]	Wang SY, Hsu SH, Gross CP, Sanft T, Davidoff AJ, Ma X, Yu JB. Association between Time since Cancer Diagnosis and Health-Related Quality of Life: A Population-Level Analysis. Value Health. 2016 Jul-Aug; 19 (5): 631-638.
[13]	Wan G, Counte M, Cella D, Hernandez L, McGuire DB, Deasay S, Shiomoto G, Hahn EA. The impact of socio-cultural and clinical factors on health-related quality of life reports among Hispanic and African-American cancer patients. J Outcome Meas. 1999; 3 (3): 200–215.
[14]	kholoud A, Abdul-Monim B, Mohammed S, Mohammed A. Impact of Radiotherapy Treatment on Jordanian Cancer Patients Quality of Life and Fatigue. International Journal of Advanced Nursing Studies. 2014; 3 (1): 6-12.
[15]	Mei F, Amber D, Guth J, Charles M. Cleland, Caitlin E. Ryan, Kristen R. Weaver, Jeanna M. Qiu, Robin Kleinman, Joan Scagliola, Joseph J. Palamar, and Gail D’Eramo Melkus. Comorbidities and Quality of Life among Breast Cancer Survivors: A Prospective Study J Pers Med. 2015 Sep; 5 (3): 229–242.
[16]	Janda M, DiSipio T, Hurst C, Cella D and Newman B. The Queensland cancer risk study: general population norms for the functional assessment of cancer therapy–general (FACT-G). 2009 Jun; 18 (6): 606-614.
[17]	Lin LL, Brown JC, Segal S, Schmitz KH. Quality of life, body mass index, and physical activity among uterine cancer patients. Int J Gynecol Cancer. 2014 Jul; 24 (6): 1027-1032.
[18]	Laxmi K, Katherine E, Mary S, Anushree R, Maureen P, Jill PG and Clarisa RG. Quality of life in female cancer survivors: Is it related to ovarian reserve? Qual Life Res. 2014 Mar; 23 (2): 585–592.

Cite This Article

Plain Text BibTeX RIS

APA Style

Abdelrahim Saad Shoulah, Mahmoud Ali Saleh, Shereen Mohamed Abdelwahab, Mona Ahmad Elawady, Eman Fadel Elsheikh. (2017). Evaluation of Health Related Quality of Life in Cancer Patients Receiving Chemotherapy. Science Journal of Public Health, 5(5-1), 1-7. https://doi.org/10.11648/j.sjph.s.2017050501.11

Copy | Download

ACS Style

Abdelrahim Saad Shoulah; Mahmoud Ali Saleh; Shereen Mohamed Abdelwahab; Mona Ahmad Elawady; Eman Fadel Elsheikh. Evaluation of Health Related Quality of Life in Cancer Patients Receiving Chemotherapy. Sci. J. Public Health 2017, 5(5-1), 1-7. doi: 10.11648/j.sjph.s.2017050501.11

Copy | Download

AMA Style

Abdelrahim Saad Shoulah, Mahmoud Ali Saleh, Shereen Mohamed Abdelwahab, Mona Ahmad Elawady, Eman Fadel Elsheikh. Evaluation of Health Related Quality of Life in Cancer Patients Receiving Chemotherapy. Sci J Public Health. 2017;5(5-1):1-7. doi: 10.11648/j.sjph.s.2017050501.11

Copy | Download

@article{10.11648/j.sjph.s.2017050501.11,
  author = {Abdelrahim Saad Shoulah and Mahmoud Ali Saleh and Shereen Mohamed Abdelwahab and Mona Ahmad Elawady and Eman Fadel Elsheikh},
  title = {Evaluation of Health Related Quality of Life in Cancer Patients Receiving Chemotherapy},
  journal = {Science Journal of Public Health},
  volume = {5},
  number = {5-1},
  pages = {1-7},
  doi = {10.11648/j.sjph.s.2017050501.11},
  url = {https://doi.org/10.11648/j.sjph.s.2017050501.11},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.sjph.s.2017050501.11},
  abstract = {Background: Cancer is considered as the second leading cause of death worldwide. Objectives: To evaluate health-related quality of life (HRQOL) among cancer patients receiving chemotherapy and to identify the most important determinants that affect them. Methods: This cross-sectional study included 190 cancer patients who have been received chemotherapy at the day care clinics in Nasser Institute Cancer Center (NICC). To address our subject, we analyzed HRQOL, as measured by the Functional Assessment of Cancer Therapy-General questionnaire (FACT-G), Arabic Version 4, and depicted the complex relations among physical, psychological, social, and cultural factors. Results: From cancer patients (190) [aged from 23 to 81 years (50.63±11.79)] 153 patients (80.53%) were females. FACT-G total score ranged from 21.2 to 87 (63.24±12.74) which is considered relatively poor (the physical and functional domains were more affected). HRQOL of the study group was not affected by gender, employment status, education level, smoking habits or marital status while it was negatively correlated with age, time since diagnosis of cancer, and disease stage. Patients’ HRQOL shown to be affected by the presence of many variables like low-performance status as evaluated by Eastern Cooperative Oncology Group (ECOG) scale, associated comorbidities, exposure to radiotherapy, history of surgery, and absence of menstrual status in female patients. A positive correlation was found between HRQOL and higher body mass index (BMI), and it was observed that the HRQOL of patients with higher perceived financial status was better. Conclusion: The HRQOL of cancer patients tended to be lower than the norms of the healthy people. Preplanned health programs should be designed to support early disease diagnosis, optimizing treatment choices, controlling of associated comorbidities, improving patients’ performance status as well as working on improving health insurance coverage.},
 year = {2017}
}

Copy | Download

TY  - JOUR
T1  - Evaluation of Health Related Quality of Life in Cancer Patients Receiving Chemotherapy
AU  - Abdelrahim Saad Shoulah
AU  - Mahmoud Ali Saleh
AU  - Shereen Mohamed Abdelwahab
AU  - Mona Ahmad Elawady
AU  - Eman Fadel Elsheikh
Y1  - 2017/02/14
PY  - 2017
N1  - https://doi.org/10.11648/j.sjph.s.2017050501.11
DO  - 10.11648/j.sjph.s.2017050501.11
T2  - Science Journal of Public Health
JF  - Science Journal of Public Health
JO  - Science Journal of Public Health
SP  - 1
EP  - 7
PB  - Science Publishing Group
SN  - 2328-7950
UR  - https://doi.org/10.11648/j.sjph.s.2017050501.11
AB  - Background: Cancer is considered as the second leading cause of death worldwide. Objectives: To evaluate health-related quality of life (HRQOL) among cancer patients receiving chemotherapy and to identify the most important determinants that affect them. Methods: This cross-sectional study included 190 cancer patients who have been received chemotherapy at the day care clinics in Nasser Institute Cancer Center (NICC). To address our subject, we analyzed HRQOL, as measured by the Functional Assessment of Cancer Therapy-General questionnaire (FACT-G), Arabic Version 4, and depicted the complex relations among physical, psychological, social, and cultural factors. Results: From cancer patients (190) [aged from 23 to 81 years (50.63±11.79)] 153 patients (80.53%) were females. FACT-G total score ranged from 21.2 to 87 (63.24±12.74) which is considered relatively poor (the physical and functional domains were more affected). HRQOL of the study group was not affected by gender, employment status, education level, smoking habits or marital status while it was negatively correlated with age, time since diagnosis of cancer, and disease stage. Patients’ HRQOL shown to be affected by the presence of many variables like low-performance status as evaluated by Eastern Cooperative Oncology Group (ECOG) scale, associated comorbidities, exposure to radiotherapy, history of surgery, and absence of menstrual status in female patients. A positive correlation was found between HRQOL and higher body mass index (BMI), and it was observed that the HRQOL of patients with higher perceived financial status was better. Conclusion: The HRQOL of cancer patients tended to be lower than the norms of the healthy people. Preplanned health programs should be designed to support early disease diagnosis, optimizing treatment choices, controlling of associated comorbidities, improving patients’ performance status as well as working on improving health insurance coverage.
VL  - 5
IS  - 5-1
ER  -

Copy | Download

Author Information

Abdelrahim Saad Shoulah

Department of Community Medicine, Faculty of Medicine, Benha University, Benha, Egypt
Mahmoud Ali Saleh

Department of Community Medicine, Faculty of Medicine, Benha University, Benha, Egypt
Shereen Mohamed Abdelwahab

Department of Community Medicine, Faculty of Medicine, Benha University, Benha, Egypt
Mona Ahmad Elawady

Department of Community Medicine, Faculty of Medicine, Benha University, Benha, Egypt
Eman Fadel Elsheikh

Department of Community Medicine, Faculty of Medicine, Benha University, Benha, Egypt

Download PDF

Sections

Plain Text BibTeX RIS

APA Style

Abdelrahim Saad Shoulah, Mahmoud Ali Saleh, Shereen Mohamed Abdelwahab, Mona Ahmad Elawady, Eman Fadel Elsheikh. (2017). Evaluation of Health Related Quality of Life in Cancer Patients Receiving Chemotherapy. Science Journal of Public Health, 5(5-1), 1-7. https://doi.org/10.11648/j.sjph.s.2017050501.11

Copy | Download

ACS Style

Abdelrahim Saad Shoulah; Mahmoud Ali Saleh; Shereen Mohamed Abdelwahab; Mona Ahmad Elawady; Eman Fadel Elsheikh. Evaluation of Health Related Quality of Life in Cancer Patients Receiving Chemotherapy. Sci. J. Public Health 2017, 5(5-1), 1-7. doi: 10.11648/j.sjph.s.2017050501.11

Copy | Download

AMA Style

Abdelrahim Saad Shoulah, Mahmoud Ali Saleh, Shereen Mohamed Abdelwahab, Mona Ahmad Elawady, Eman Fadel Elsheikh. Evaluation of Health Related Quality of Life in Cancer Patients Receiving Chemotherapy. Sci J Public Health. 2017;5(5-1):1-7. doi: 10.11648/j.sjph.s.2017050501.11

Copy | Download

@article{10.11648/j.sjph.s.2017050501.11,
  author = {Abdelrahim Saad Shoulah and Mahmoud Ali Saleh and Shereen Mohamed Abdelwahab and Mona Ahmad Elawady and Eman Fadel Elsheikh},
  title = {Evaluation of Health Related Quality of Life in Cancer Patients Receiving Chemotherapy},
  journal = {Science Journal of Public Health},
  volume = {5},
  number = {5-1},
  pages = {1-7},
  doi = {10.11648/j.sjph.s.2017050501.11},
  url = {https://doi.org/10.11648/j.sjph.s.2017050501.11},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.sjph.s.2017050501.11},
  abstract = {Background: Cancer is considered as the second leading cause of death worldwide. Objectives: To evaluate health-related quality of life (HRQOL) among cancer patients receiving chemotherapy and to identify the most important determinants that affect them. Methods: This cross-sectional study included 190 cancer patients who have been received chemotherapy at the day care clinics in Nasser Institute Cancer Center (NICC). To address our subject, we analyzed HRQOL, as measured by the Functional Assessment of Cancer Therapy-General questionnaire (FACT-G), Arabic Version 4, and depicted the complex relations among physical, psychological, social, and cultural factors. Results: From cancer patients (190) [aged from 23 to 81 years (50.63±11.79)] 153 patients (80.53%) were females. FACT-G total score ranged from 21.2 to 87 (63.24±12.74) which is considered relatively poor (the physical and functional domains were more affected). HRQOL of the study group was not affected by gender, employment status, education level, smoking habits or marital status while it was negatively correlated with age, time since diagnosis of cancer, and disease stage. Patients’ HRQOL shown to be affected by the presence of many variables like low-performance status as evaluated by Eastern Cooperative Oncology Group (ECOG) scale, associated comorbidities, exposure to radiotherapy, history of surgery, and absence of menstrual status in female patients. A positive correlation was found between HRQOL and higher body mass index (BMI), and it was observed that the HRQOL of patients with higher perceived financial status was better. Conclusion: The HRQOL of cancer patients tended to be lower than the norms of the healthy people. Preplanned health programs should be designed to support early disease diagnosis, optimizing treatment choices, controlling of associated comorbidities, improving patients’ performance status as well as working on improving health insurance coverage.},
 year = {2017}
}

Copy | Download

TY  - JOUR
T1  - Evaluation of Health Related Quality of Life in Cancer Patients Receiving Chemotherapy
AU  - Abdelrahim Saad Shoulah
AU  - Mahmoud Ali Saleh
AU  - Shereen Mohamed Abdelwahab
AU  - Mona Ahmad Elawady
AU  - Eman Fadel Elsheikh
Y1  - 2017/02/14
PY  - 2017
N1  - https://doi.org/10.11648/j.sjph.s.2017050501.11
DO  - 10.11648/j.sjph.s.2017050501.11
T2  - Science Journal of Public Health
JF  - Science Journal of Public Health
JO  - Science Journal of Public Health
SP  - 1
EP  - 7
PB  - Science Publishing Group
SN  - 2328-7950
UR  - https://doi.org/10.11648/j.sjph.s.2017050501.11
AB  - Background: Cancer is considered as the second leading cause of death worldwide. Objectives: To evaluate health-related quality of life (HRQOL) among cancer patients receiving chemotherapy and to identify the most important determinants that affect them. Methods: This cross-sectional study included 190 cancer patients who have been received chemotherapy at the day care clinics in Nasser Institute Cancer Center (NICC). To address our subject, we analyzed HRQOL, as measured by the Functional Assessment of Cancer Therapy-General questionnaire (FACT-G), Arabic Version 4, and depicted the complex relations among physical, psychological, social, and cultural factors. Results: From cancer patients (190) [aged from 23 to 81 years (50.63±11.79)] 153 patients (80.53%) were females. FACT-G total score ranged from 21.2 to 87 (63.24±12.74) which is considered relatively poor (the physical and functional domains were more affected). HRQOL of the study group was not affected by gender, employment status, education level, smoking habits or marital status while it was negatively correlated with age, time since diagnosis of cancer, and disease stage. Patients’ HRQOL shown to be affected by the presence of many variables like low-performance status as evaluated by Eastern Cooperative Oncology Group (ECOG) scale, associated comorbidities, exposure to radiotherapy, history of surgery, and absence of menstrual status in female patients. A positive correlation was found between HRQOL and higher body mass index (BMI), and it was observed that the HRQOL of patients with higher perceived financial status was better. Conclusion: The HRQOL of cancer patients tended to be lower than the norms of the healthy people. Preplanned health programs should be designed to support early disease diagnosis, optimizing treatment choices, controlling of associated comorbidities, improving patients’ performance status as well as working on improving health insurance coverage.
VL  - 5
IS  - 5-1
ER  -

Copy | Download